A detailed history of Bellevue Group Ag transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 53,623 shares of TMO stock, worth $28.1 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
53,623
Previous 42,626 25.8%
Holding current value
$28.1 Million
Previous $23.6 Million 40.71%
% of portfolio
0.56%
Previous 0.39%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$531.86 - $624.21 $5.85 Million - $6.86 Million
10,997 Added 25.8%
53,623 $33.2 Million
Q2 2024

Aug 14, 2024

BUY
$541.52 - $599.02 $1.45 Million - $1.6 Million
2,670 Added 6.68%
42,626 $23.6 Million
Q1 2024

May 15, 2024

BUY
$528.82 - $599.43 $2.44 Million - $2.77 Million
4,614 Added 13.06%
39,956 $23.2 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $13.4 Million - $16.6 Million
-31,126 Reduced 46.83%
35,342 $18.8 Million
Q3 2023

Nov 14, 2023

SELL
$498.29 - $574.41 $14.8 Million - $17 Million
-29,633 Reduced 30.84%
66,468 $33.6 Million
Q2 2023

Aug 14, 2023

BUY
$508.46 - $591.13 $4.97 Million - $5.77 Million
9,768 Added 11.31%
96,101 $50.1 Million
Q1 2023

May 15, 2023

BUY
$535.0 - $604.82 $1.61 Million - $1.82 Million
3,004 Added 3.6%
86,333 $49.8 Million
Q4 2022

Feb 14, 2023

BUY
$484.71 - $571.37 $5.42 Million - $6.39 Million
11,185 Added 15.5%
83,329 $45.9 Million
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $165,343 - $197,063
326 Added 0.45%
72,144 $36.6 Million
Q2 2022

Aug 11, 2022

SELL
$500.9 - $612.21 $408,233 - $498,951
-815 Reduced 1.12%
71,818 $39 Million
Q1 2022

May 13, 2022

SELL
$524.0 - $644.92 $13.5 Million - $16.6 Million
-25,695 Reduced 26.13%
72,633 $42.9 Million
Q4 2021

Feb 10, 2022

BUY
$569.0 - $667.24 $6.51 Million - $7.64 Million
11,449 Added 13.18%
98,328 $65.6 Million
Q3 2021

Nov 12, 2021

BUY
$509.53 - $609.78 $22.9 Million - $27.4 Million
44,905 Added 106.98%
86,879 $49.6 Million
Q2 2021

Aug 12, 2021

BUY
$441.0 - $508.24 $2.38 Million - $2.74 Million
5,400 Added 14.76%
41,974 $21.2 Million
Q1 2021

May 12, 2021

SELL
$439.85 - $518.83 $3.47 Million - $4.09 Million
-7,881 Reduced 17.73%
36,574 $16.7 Million
Q4 2020

Feb 16, 2021

SELL
$435.06 - $527.66 $11.5 Million - $13.9 Million
-26,410 Reduced 37.27%
44,455 $20.7 Million
Q3 2020

Nov 16, 2020

BUY
$359.77 - $441.52 $494,323 - $606,648
1,374 Added 1.98%
70,865 $31.3 Million
Q2 2020

Aug 13, 2020

BUY
$275.2 - $362.34 $8.24 Million - $10.8 Million
29,939 Added 75.7%
69,491 $25.2 Million
Q1 2020

May 14, 2020

SELL
$255.3 - $340.05 $6.45 Million - $8.58 Million
-25,245 Reduced 38.96%
39,552 $11.2 Million
Q4 2019

Feb 14, 2020

BUY
$271.93 - $328.04 $2.06 Million - $2.48 Million
7,561 Added 13.21%
64,797 $21.1 Million
Q3 2019

Nov 14, 2019

BUY
$268.46 - $305.43 $56,913 - $64,751
212 Added 0.37%
57,236 $16.7 Million
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $4.68 Million - $5.37 Million
18,166 Added 46.75%
57,024 $16.7 Million
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $459,560 - $592,877
2,166 Added 5.9%
38,858 $10.6 Million
Q4 2018

Feb 12, 2019

BUY
$208.47 - $251.98 $463,011 - $559,647
2,221 Added 6.44%
36,692 $8.21 Million
Q3 2018

Nov 13, 2018

BUY
$205.57 - $244.32 $1.1 Million - $1.3 Million
5,340 Added 18.33%
34,471 $8.41 Million
Q2 2018

Aug 07, 2018

BUY
$203.14 - $219.53 $1.07 Million - $1.16 Million
5,283 Added 22.15%
29,131 $6.03 Million
Q1 2018

May 09, 2018

SELL
$192.98 - $224.11 $378,240 - $439,255
-1,960 Reduced 7.59%
23,848 $4.92 Million
Q3 2017

Nov 13, 2017

BUY
$171.74 - $194.04 $1.92 Million - $2.17 Million
11,208 Added 76.77%
25,808 $4.88 Million
Q2 2017

Aug 14, 2017

BUY
N/A
14,600
14,600 $2.55 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.